Benzinga | Oct 29, 2020 05:08PM EDT

Invacare Q3 EPS $(0.10) Beats $(0.18) Estimate, Sales $211.91M Beat $202.35M Estimate; Raises FY20 Sales Guidance From $810M-$840M To At Least $840M vs $826M Estimate, Adj. EBITDA From $27M-$30M to $28M-$32M

Invacare (NYSE:IVC) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $211.91 million which beat the analyst consensus estimate of $202.35 million by 4.72 percent. This is a 10.12 percent decrease over sales of $235.77 million the same period last year.